OnabotulinumtoxinA for Systemic Sclerosis-associated Raynaud's Phenomenon: A Multi-Institutional Study on Accessibility and Effectiveness

J Drugs Dermatol. 2021 Nov 1;20(11):1257-1259. doi: 10.36849/jdd.6135.

Abstract

Raynaud’s phenomenon (RP), a common presenting symptom of systemic sclerosis (SSc), is a painful and debilitating condition of the digits caused by increased vascular reactivity.1,2.

Publication types

  • Multicenter Study

MeSH terms

  • Botulinum Toxins, Type A*
  • Humans
  • Pain
  • Raynaud Disease* / diagnosis
  • Raynaud Disease* / drug therapy
  • Raynaud Disease* / etiology
  • Scleroderma, Systemic* / complications
  • Scleroderma, Systemic* / diagnosis
  • Scleroderma, Systemic* / drug therapy

Substances

  • Botulinum Toxins, Type A